The latest news, articles, and events from the attorneys at Lerch, Early & Brewer.

Lerch Early Insights

COVID-19 Resource Center

Lerch Early is monitoring COVID-19 and its impact on our clients and communities.

As part of this effort, we're constantly working on fresh content to both inform and to meet your needs. Please check out our

COVID-19 Resource Center


Success Story: Technology Joint Venture Trial with MedStar-Georgetown Medical Center

Two of the firm’s litigation principals, Stan Reed and Brad McCullough, were part of a trial team that successfully represented MedStar-Georgetown Medical Center (also known as Georgetown University Hospital or “GUH”) in a very complex trial in the Circuit Court for Montgomery County, Maryland. A company claimed to be a joint venture partner with GUH with respect to GUH’s use of CyberKnife technology to treat cancer patients, and also claimed that GUH had breached the parties’ contract. The company sought remedies against GUH amounting to more than $10 million. After a two-week trial, the Court ruled in GUH’s favor, finding that no joint venture
partnership existed and that GUH had complied with its contractual duties.

Please note that every case is different, and prior results do not guarantee future success.

This Success Story originally appeared in Lerch, Early & Brewer's Legal Update Winter 2010 issue.


Email Confirmation

Thank you for your interest in Lerch, Early & Brewer. Please be aware that unsolicited e-mails and information sent to Lerch Early though our web site will not be considered confidential, may not receive a response, and do not create an attorney-client relationship with Lerch Early Brewer. If you are not already a client of Lerch Early, do not include anything confidential or secret in this e-mail. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not authorized to do so.

By clicking "OK" you acknowledge that, unless you are a current client, Lerch Early does not have any obligation to maintain the confidentiality of any information you send us.